Adaptive Biotechnologies Corporation (ADPT)
USD 7.84
(1.49%)
USD 7.84
(1.49%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 94.72 Million USD | -43.1% |
| 2022 | 127.39 Million USD | 21.28% |
| 2021 | 105.04 Million USD | 38.48% |
| 2020 | 75.85 Million USD | 20.79% |
| 2019 | 62.79 Million USD | 74.46% |
| 2018 | 35.99 Million USD | 58.09% |
| 2017 | 22.76 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 21.08 Million USD | -11.48% |
| 2024 Q1 | 23.82 Million USD | 14.66% |
| 2023 Q1 | 18.96 Million USD | -50.88% |
| 2023 FY | 72.49 Million USD | -43.1% |
| 2023 Q3 | 18.57 Million USD | -40.12% |
| 2023 Q4 | 20.77 Million USD | 11.86% |
| 2023 Q2 | 31.01 Million USD | 63.53% |
| 2022 Q4 | 38.6 Million USD | 17.27% |
| 2022 Q3 | 32.92 Million USD | 8.16% |
| 2022 FY | 127.39 Million USD | 21.28% |
| 2022 Q2 | 30.43 Million USD | 19.71% |
| 2022 Q1 | 25.42 Million USD | 7.86% |
| 2021 FY | 105.04 Million USD | 38.48% |
| 2021 Q4 | 23.57 Million USD | -6.74% |
| 2021 Q3 | 25.27 Million USD | -8.88% |
| 2021 Q2 | 27.74 Million USD | -2.5% |
| 2021 Q1 | 28.45 Million USD | 18.73% |
| 2020 Q1 | 15.56 Million USD | -14.74% |
| 2020 Q2 | 16.07 Million USD | 3.27% |
| 2020 Q4 | 23.96 Million USD | 18.36% |
| 2020 Q3 | 20.24 Million USD | 25.94% |
| 2020 FY | 75.85 Million USD | 20.79% |
| 2019 Q1 | 7.67 Million USD | -35.57% |
| 2019 FY | 62.79 Million USD | 74.46% |
| 2019 Q4 | 18.25 Million USD | -10.75% |
| 2019 Q3 | 20.45 Million USD | 24.71% |
| 2019 Q2 | 16.4 Million USD | 113.65% |
| 2018 FY | 35.99 Million USD | 58.09% |
| 2018 Q1 | 5.72 Million USD | 0.0% |
| 2018 Q4 | 11.91 Million USD | 0.75% |
| 2018 Q3 | 11.82 Million USD | 81.3% |
| 2018 Q2 | 6.52 Million USD | 13.94% |
| 2017 FY | 22.76 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Caribou Biosciences, Inc. | -77.59 Million USD | 222.069% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 809.119% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 2074.218% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 19352.642% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -18292.816% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 197.703% |
| Agenus Inc. | 139.61 Million USD | 32.154% |
| Fortress Biotech, Inc. | 57.85 Million USD | -63.73% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 66200.725% |
| Novavax, Inc. | 639.93 Million USD | 85.198% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 14365.512% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -349.755% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 2665.628% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -225.185% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 21.375% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 93.76% |
| AlloVir, Inc. | -398 Thousand USD | 23899.749% |
| Aptorum Group Limited | -1.11 Million USD | 8597.714% |
| Ardelyx, Inc. | 106.66 Million USD | 11.192% |
| Bicycle Therapeutics plc | -129.52 Million USD | 173.134% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -78835.833% |
| Chimerix, Inc. | 324 Thousand USD | -29135.494% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 403.914% |
| CRISPR Therapeutics AG | 240.95 Million USD | 60.689% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1103.443% |
| Precision BioSciences, Inc. | 40.47 Million USD | -134.046% |
| Dyadic International, Inc. | 922.95 Thousand USD | -10162.992% |
| Elevation Oncology, Inc. | -39 Thousand USD | 242979.487% |
| Fortress Biotech, Inc. | 57.85 Million USD | -63.73% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Alkermes plc | 1.37 Billion USD | 93.109% |
| Immix Biopharma, Inc. | -5468.00 USD | 1732415.289% |
| Innoviva, Inc. | 261.06 Million USD | 63.717% |
| IO Biotech, Inc. | -756 Thousand USD | 12629.497% |
| Jaguar Health, Inc. | 7.72 Million USD | -1126.346% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 20.901% |
| ContextLogic Inc. | 59 Million USD | -60.547% |
| AbCellera Biologics Inc. | 38.02 Million USD | -149.107% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 54276.032% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 172323.636% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 60.653% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 18074.004% |
| MEI Pharma, Inc. | 49.32 Million USD | -92.031% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -11710.848% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -226.013% |
| NextCure, Inc. | -3.68 Million USD | 2671.2% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -471.412% |
| ChromaDex Corporation | 50.78 Million USD | -86.536% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 189.258% |
| Incyte Corporation | 3.44 Billion USD | 97.247% |
| Opthea Limited | 21.72 Thousand USD | -436009.576% |
| MiMedx Group, Inc. | 266.84 Million USD | 64.502% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 214463.628% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -339.652% |
| Psyence Biomedical Ltd. | -240.00 USD | 39468016.667% |
| Vaxcyte, Inc. | -75 Million USD | 226.297% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 165335.67% |
| Pharming Group N.V. | 220.1 Million USD | 56.964% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -9287.81% |
| Onconetix, Inc. | -1.12 Million USD | 8503.65% |
| Acelyrin, Inc. | -115 Thousand USD | 82467.826% |
| PureTech Health plc | -1.6 Million USD | 6009.108% |
| Pyxis Oncology, Inc. | -2 Million USD | 4836.15% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 152.215% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 18430.669% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 80041.093% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 13.709% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -397.416% |
| Seer, Inc. | 7.02 Million USD | -1247.986% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 308.986% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 530.814% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 942523.639% |
| Summit Therapeutics Inc. | -2.05 Million USD | 4720.634% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 16688.967% |
| Senti Biosciences, Inc. | -2.68 Million USD | 3630.488% |
| ImmuCell Corporation | 4.39 Million USD | -2054.615% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 196.443% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 302.231% |
| Precigen, Inc. | 106 Thousand USD | -89261.321% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 1894560.0% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 426.992% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -2238.262% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 29.974% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 2502.888% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -222.33% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -2063.614% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -18997.379% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -22240.33% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 115615.854% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 9.007% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 196.496% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 40928.879% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -15453.859% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 69.802% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -3579.992% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 186783.09% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 1434.503% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 20060.805% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 910898.077% |
| Soligenix, Inc. | 97.31 Thousand USD | -97240.486% |
| Century Therapeutics, Inc. | -10.8 Million USD | 976.335% |
| Kura Oncology, Inc. | -849 Thousand USD | 11257.008% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 241.159% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 64537.415% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 4.358% |
| Autolus Therapeutics plc | -4.86 Million USD | 2046.23% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -128.877% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 56482.738% |
| GRI Bio, Inc. | 10.84 Million USD | -773.748% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -3629.273% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1190.399% |
| IGM Biosciences, Inc. | -211.66 Million USD | 144.752% |
| INmune Bio, Inc. | 155 Thousand USD | -61011.613% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -52.929% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 6388.493% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 14707.513% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 323673.82% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -23462.935% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 4845.641% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 30362.939% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -0.277% |
| Verastem, Inc. | -62 Thousand USD | 152879.032% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -3790.062% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 36392.337% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -3029.27% |
| Histogen Inc. | 3.76 Million USD | -2413.213% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -16339.856% |
| Surrozen, Inc. | -27.23 Million USD | 447.863% |
| Organovo Holdings, Inc. | -5.38 Million USD | 1857.71% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 7961.613% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 469.334% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -372.387% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 4784089.899% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -1461.431% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 141201.726% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 38.806% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -64867.764% |
| Apollomics, Inc. | 127 Thousand USD | -74485.039% |
| Amarin Corporation plc | 165.54 Million USD | 42.78% |
| Mesoblast Limited | -9.81 Million USD | 1065.084% |
| Turnstone Biologics Corp. | 16.5 Million USD | -473.87% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 185.731% |
| Synaptogenix, Inc. | -6347.00 USD | 1492505.861% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 185831.373% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 41.299% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 94.611% |
| Better Therapeutics, Inc. | -2.72 Million USD | 3570.978% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 184.453% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 71.982% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 830420.827% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 1613.147% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 8649.007% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1194.384% |
| Insmed Incorporated | 239.63 Million USD | 60.472% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -2547.373% |
| OmniAb, Inc. | 14.66 Million USD | -545.824% |
| Alector, Inc. | -95.05 Million USD | 199.653% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 24.596% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 317.939% |
| Zai Lab Limited | 170.9 Million USD | 44.575% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -15.689% |
| Aura Biosciences, Inc. | -1.29 Million USD | 7414.517% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -72763.846% |
| Immunic, Inc. | -111 Thousand USD | 85436.036% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -497.471% |
| Veracyte, Inc. | 248.14 Million USD | 61.828% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.355% |
| FibroGen, Inc. | 128.9 Million USD | 26.517% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 16794958.156% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 911.896% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 97.213% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -24250.386% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 73.343% |
| TG Therapeutics, Inc. | 219.1 Million USD | 56.769% |
| Galecto, Inc. | -830 Thousand USD | 11512.41% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 6939.206% |
| Fortrea Holdings Inc. | 424 Million USD | 77.66% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 209.93% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 16805.996% |
| XBiotech Inc. | -1.74 Million USD | 5531.365% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 8649.007% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 303.832% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 225.404% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -29.045% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -463.727% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 75.652% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 290.793% |
| Vaxxinity, Inc. | -2.23 Million USD | 4340.063% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 71.011% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 936.492% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -287.399% |
| NexImmune, Inc. | -1.02 Million USD | 9341.521% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -1754029.63% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 1433.065% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.162% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 141843.607% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 2767.502% |
| Ainos, Inc. | -253.73 Thousand USD | 37431.762% |
| Pluri Inc. | 322 Thousand USD | -29317.081% |
| Prothena Corporation plc | -129.2 Million USD | 173.314% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -87.853% |
| Celularity Inc. | 6.75 Million USD | -1302.265% |
| Rallybio Corporation | -150 Thousand USD | 63248.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 390.499% |
| MeiraGTx Holdings plc | 287 Thousand USD | -32904.53% |
| Omeros Corporation | -69.77 Million USD | 235.747% |
| Humacyte, Inc. | -76.55 Million USD | 223.74% |
| Immunocore Holdings plc | 248.39 Million USD | 61.865% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 724.451% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -51.843% |
| Blueprint Medicines Corporation | 236.58 Million USD | 59.962% |
| CalciMedica, Inc. | -58 Thousand USD | 163415.517% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 6742.567% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 3430.626% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 406.895% |
| Pulmatrix, Inc. | -8.22 Million USD | 1252.348% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 8195.983% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 23840.1% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 123.752% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -3312.722% |
| Cytokinetics, Incorporated | -322.59 Million USD | 129.363% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -10887.409% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 27878.006% |
| Vor Biopharma Inc. | -3.49 Million USD | 2812.572% |
| Roivant Sciences Ltd. | 109.23 Million USD | 13.285% |
| Evogene Ltd. | 1.39 Million USD | -6670.765% |
| ProKidney Corp. | -3.16 Million USD | 3089.05% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 315.711% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1281.406% |
| CorMedix Inc. | -205.56 Thousand USD | 46180.015% |
| BioLineRx Ltd. | 1.1 Million USD | -8449.007% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 220.404% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 287139.394% |
| Atai Life Sciences N.V. | -5000.00 USD | 1894560.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 77831.641% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 98769.792% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 6919.51% |
| Sagimet Biosciences Inc. | 2 Million USD | -4636.15% |
| MediciNova, Inc. | 979.7 Thousand USD | -9568.523% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 212.339% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 100277.674% |
| GeoVax Labs, Inc. | -20.72 Million USD | 557.14% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 61.264% |
| Biomea Fusion, Inc. | -4.2 Million USD | 2354.773% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 89.141% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1175.559% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 30655.806% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 789458.333% |
| Absci Corporation | -41.84 Million USD | 326.345% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1894560.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 224.027% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 3948.964% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 55.682% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 10166.206% |
| Allakos Inc. | -6.14 Million USD | 1642.469% |
| Imunon, Inc. | -720 Thousand USD | 13255.881% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 237.288% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 80.096% |
| BioAtla, Inc. | -103.73 Million USD | 191.316% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 830420.827% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 53315.169% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 139.01% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 30557.556% |
| XOMA Corporation | 3.86 Million USD | -2353.328% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 235.154% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -540.28% |
| aTyr Pharma, Inc. | -2.38 Million USD | 4066.625% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -660.217% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 326731.034% |
| Viridian Therapeutics, Inc. | -1 Million USD | 9497.123% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -728638361.538% |
| Akari Therapeutics, Plc | -4000.00 USD | 2368175.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 85.127% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -48548.746% |
| UroGen Pharma Ltd. | 73.35 Million USD | -29.135% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 454.848% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -815774.246% |
| Orgenesis Inc. | -5.72 Million USD | 1754.55% |
| Entera Bio Ltd. | -56 Thousand USD | 169248.214% |
| GH Research PLC | -315 Thousand USD | 30170.794% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 50217.989% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 18142.476% |
| Xencor, Inc. | -85.26 Million USD | 211.099% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 42965.547% |
| Replimune Group, Inc. | -2.65 Million USD | 3667.721% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 9560.607% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 46.738% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -48548.746% |
| Portage Biotech Inc. | -54 Thousand USD | 175512.963% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 100277.674% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 25225.464% |
| OncoCyte Corporation | 413 Thousand USD | -22835.351% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 2107396.997% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 42668118.018% |
| Purple Biotech Ltd. | -196 Thousand USD | 48428.061% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -956.233% |
| scPharmaceuticals Inc. | 9.78 Million USD | -868.34% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1006.878% |
| HilleVax, Inc. | -2.15 Million USD | 4493.46% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 97752.577% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 631418.315% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 14280.09% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 411939.13% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1262036.863% |
| Savara Inc. | -44.26 Million USD | 314.005% |
| Curis, Inc. | 9.81 Million USD | -865.478% |
| Daré Bioscience, Inc. | 2.76 Million USD | -3320.193% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 76007.139% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 5578.485% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 41645.175% |
| BeiGene, Ltd. | 2.07 Billion USD | 95.444% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 3487.925% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 123.701% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -67.095% |
| Erasca, Inc. | -3.73 Million USD | 2638.13% |
| bluebird bio, Inc. | -4.03 Million USD | 2450.447% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 335782.897% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 95.026% |
| DBV Technologies S.A. | 15.72 Million USD | -502.257% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 335782.897% |
| Moderna, Inc. | 2.15 Billion USD | 95.605% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 10452.24% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1083.15% |
| Molecular Templates, Inc. | 50.39 Million USD | -87.961% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 17772.201% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 29.199% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 1622.388% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 340.762% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 185.238% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 2739.994% |
| MacroGenics, Inc. | 50.52 Million USD | -87.47% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 1653.345% |
| Prime Medicine, Inc. | -147.9 Million USD | 164.043% |
| Aditxt, Inc. | -111.66 Thousand USD | 84931.632% |
| Adagene Inc. | 18.11 Million USD | -422.999% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -19310.451% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 32.438% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 39.986% |
| SciSparc Ltd. | 2.19 Million USD | -4213.434% |
| Vericel Corporation | 135.57 Million USD | 30.133% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 378250.824% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 305835.588% |
| Generation Bio Co. | -73.91 Million USD | 228.158% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 21775.744% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -73.425% |
| Invivyd, Inc. | -2.02 Million USD | 4770.759% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 131.486% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 91674.663% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 1.707% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 3.627% |
| ADMA Biologics, Inc. | 88.21 Million USD | -7.374% |
| Clene Inc. | 533 Thousand USD | -17671.67% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -292.892% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 9997.91% |
| GeoVax Labs, Inc. | -20.72 Million USD | 557.14% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -4664.738% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 48846.887% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -90.188% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 1435.632% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 11430.502% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -13.556% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -129458.759% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -78.178% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 154.694% |
| Trevena, Inc. | 1.45 Million USD | -6410.172% |
| Surrozen, Inc. | -27.23 Million USD | 447.863% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 26933.711% |
| Cingulate Inc. | -582.91 Thousand USD | 16349.798% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 305658.065% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 580.852% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1251394.584% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 10851.759% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 86.085% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 9687.348% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 168221.472% |
| Kronos Bio, Inc. | 1.37 Million USD | -6804.009% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 276.505% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 32539.384% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 19497.969% |
| ImmunityBio, Inc. | -17.89 Million USD | 629.475% |
| Korro Bio, Inc. | -3.63 Million USD | 2709.449% |
| Kineta, Inc. | 5.43 Million USD | -1643.475% |
| BioVie Inc. | -229.37 Thousand USD | 41395.771% |
| Codexis, Inc. | 57.33 Million USD | -65.213% |
| Celularity Inc. | 6.75 Million USD | -1302.265% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -2260.404% |
| Celcuity Inc. | -142.77 Thousand USD | 66445.642% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -187136.608% |
| Cibus, Inc. | 1.42 Million USD | -6561.252% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 25427.005% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 513.295% |
| IN8bio, Inc. | -2.5 Million USD | 3887.405% |
| Kodiak Sciences Inc. | -25.94 Million USD | 465.063% |
| Annexon, Inc. | -3.26 Million USD | 2999.388% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 4734.198% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 326.952% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -14700.469% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 87.833% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 45.233% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 5085.421% |
| Arcellx, Inc. | 108.27 Million USD | 12.52% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 392.635% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -19.594% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 547.821% |
| Moolec Science SA | -143.3 Thousand USD | 66198.88% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 323.836% |
| Geron Corporation | -123.5 Million USD | 176.697% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -2781.746% |
| Royalty Pharma plc | 1.79 Billion USD | 94.72% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 235.145% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 2622552.935% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -40836.337% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 185.019% |
| Humacyte, Inc. | -76.55 Million USD | 223.74% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 10079.519% |
| 89bio, Inc. | -273 Thousand USD | 34797.07% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 7635.64% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 11270.165% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 77110.569% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -8364.969% |
| Notable Labs, Ltd. | 113 Thousand USD | -83725.664% |
| Liquidia Corporation | 14.6 Million USD | -548.788% |
| Mustang Bio, Inc. | -2.22 Million USD | 4357.213% |
| Immunovant, Inc. | -231 Thousand USD | 41105.628% |
| Quantum-Si incorporated | 488 Thousand USD | -19310.451% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 270.491% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 315843.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -4987.164% |
| Acasti Pharma Inc. | -11 Thousand USD | 861218.182% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 46392.83% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 14707.513% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 156.547% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -8248.728% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 24961.68% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 4937.743% |
| PepGen Inc. | -1.18 Million USD | 8100.253% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 74685.039% |
| United Therapeutics Corporation | 2.07 Billion USD | 95.424% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 513.692% |
| Solid Biosciences Inc. | -76.56 Million USD | 223.719% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 114800.362% |
| Immuneering Corporation | -764.13 Thousand USD | 12496.059% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -142847.905% |
| Belite Bio, Inc | -399 Thousand USD | 23840.1% |
| XOMA Corporation | 3.86 Million USD | -2353.328% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 572.764% |
| Bionomics Limited | -434.44 Thousand USD | 21903.019% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 8919.646% |
| uniQure N.V. | 2.21 Million USD | -4176.433% |
| Cassava Sciences, Inc. | -89.42 Million USD | 205.927% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 202.883% |
| Forte Biosciences, Inc. | -9000.00 USD | 1052577.778% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 11444.072% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 21775.744% |
| Altimmune, Inc. | -65.37 Million USD | 244.896% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 73.836% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 8919.646% |
| Compugen Ltd. | 31.45 Million USD | -201.138% |
| Peak Bio, Inc. | 367.76 Thousand USD | -25656.113% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -286.372% |
| Benitec Biopharma Inc. | 108 Thousand USD | -87606.481% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 121539.744% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 7973.899% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 5298.847% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 79699.16% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 7973.899% |
| Instil Bio, Inc. | -4.75 Million USD | 2091.653% |
| argenx SE | 1.1 Billion USD | 91.455% |
| Immunome, Inc. | -8.9 Million USD | 1163.467% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 5111.799% |
| Verona Pharma plc | -679.62 Thousand USD | 14037.56% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 54227.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | 4071.614% |
| CervoMed Inc. | -1.29 Million USD | 7422.281% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 4035.314% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 2082.897% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -3733.387% |
| Moolec Science SA | -143.3 Thousand USD | 66198.88% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 23314.715% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 3645.649% |
| AnaptysBio, Inc. | 14.78 Million USD | -540.843% |
| Design Therapeutics, Inc. | -537 Thousand USD | 17739.292% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 22283.372% |
| NeurAxis, Inc. | 2.15 Million USD | -4292.026% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -4313.933% |
| Lumos Pharma, Inc. | 2 Million USD | -4619.631% |
| Achilles Therapeutics plc | -4.73 Million USD | 2102.064% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 54227.429% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 89736.149% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -199.2% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -10887.409% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 9278.585% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 307.963% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -220186.047% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 11623.479% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 719989.041% |
| Palisade Bio, Inc. | 246 Thousand USD | -38405.285% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 287139.394% |
| Beam Therapeutics Inc. | -59.67 Million USD | 258.739% |
| Neurogene Inc. | -3.26 Million USD | 3003.832% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 32.018% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -136.808% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 31993.266% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 2452.176% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1090.205% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -572.749% |
| Athira Pharma, Inc. | -969 Thousand USD | 9875.335% |
| Vaccinex, Inc. | -16 Million USD | 691.871% |
| HCW Biologics Inc. | -574.82 Thousand USD | 16578.609% |
| XOMA Corporation | 3.86 Million USD | -2353.328% |
| Nektar Therapeutics | 53.47 Million USD | -77.125% |
| Arvinas, Inc. | 71.8 Million USD | -31.926% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 213.494% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 250.893% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 29517.081% |
| Rezolute, Inc. | -36 Thousand USD | 263219.444% |
| Clene Inc. | 533 Thousand USD | -17671.67% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 7377280.685% |
| BeyondSpring Inc. | 1.75 Million USD | -5309.652% |
| Synlogic, Inc. | -1.92 Million USD | 5023.233% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 256108.108% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 1595.941% |
| Peak Bio, Inc. | 367.76 Thousand USD | -25656.113% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 599.515% |
| Krystal Biotech, Inc. | 47.6 Million USD | -98.977% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 32.864% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -1785.035% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 3758.362% |
| MannKind Corporation | 136.19 Million USD | 30.448% |
| Ikena Oncology, Inc. | -50.49 Million USD | 287.6% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 12.95% |
| Gossamer Bio, Inc. | -4.38 Million USD | 2260.16% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 37688.492% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1894560.0% |
| Legend Biotech Corporation | 140.92 Million USD | 32.787% |
| Mural Oncology plc | -2.56 Million USD | 3790.027% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 17291.107% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 94823.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -356.408% |
| REGENXBIO Inc. | 53.02 Million USD | -78.625% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 1868.225% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 49338.726% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 5568.995% |
| Vaxart, Inc. | -60.76 Million USD | 255.889% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 36146.503% |
| Cellectis S.A. | 18 Thousand USD | -526138.889% |
| Longeveron Inc. | 221 Thousand USD | -42761.086% |
| Repare Therapeutics Inc. | -80.07 Million USD | 218.3% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 91.334% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 7420.17% |
| Revolution Medicines, Inc. | -399.66 Million USD | 123.701% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 270737.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -193212.245% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.899% |
| Denali Therapeutics Inc. | -93.34 Million USD | 201.476% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 378250.824% |
| Veru Inc. | 7.56 Million USD | -1151.968% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 62830.464% |
| Cingulate Inc. | -582.91 Thousand USD | 16349.798% |
| Passage Bio, Inc. | -3.72 Million USD | 2645.633% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 786574.593% |
| Exicure, Inc. | -1.42 Million USD | 6756.571% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 24831.854% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -3404.366% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 18576.228% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -39.041% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 63414.551% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 259.989% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -24125.831% |
| OmniAb, Inc. | 14.66 Million USD | -545.824% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -373.781% |
| Lipocine Inc. | -2.85 Million USD | 3422.66% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 5239.609% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 1760.351% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 6388.493% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -25.767% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 145827.692% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -12.37% |
| Ocugen, Inc. | -33.53 Million USD | 382.443% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 3095.667% |
| Q32 Bio Inc. | 578 Thousand USD | -16288.062% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 35844.528% |
| Alumis Inc. Common Stock | -1.28 Million USD | 7477.181% |
| Equillium, Inc. | 35.95 Million USD | -163.427% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 5649.092% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -18818.908% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 2291415.917% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 36672.587% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -22308.401% |
| Dominari Holdings Inc. | 2.03 Million USD | -4545.562% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 51728.323% |
| vTv Therapeutics Inc. | -13.59 Million USD | 796.749% |
| Bio-Techne Corporation | 773.07 Million USD | 87.747% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -446.931% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 79.443% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 8202.908% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 495.008% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -709.806% |
| Nkarta, Inc. | -5.86 Million USD | 1713.955% |
| BioCardia, Inc. | -7.24 Million USD | 1406.704% |
| Iterum Therapeutics plc | -1.75 Million USD | 5512.743% |